ClinicalTrials.Veeva

Menu

Suboxone: (Buprenorphine/Naloxone) Comparison of Two Taper Schedules - 1

University of California, Los Angeles (UCLA) logo

University of California, Los Angeles (UCLA)

Status and phase

Completed
Phase 3

Conditions

Opioid-Related Disorders

Treatments

Drug: Buprenorphine

Study type

Interventional

Funder types

Other

Identifiers

NCT00078117
NIDA-CTN-0003-1

Details and patient eligibility

About

The purpose of this protocol is to to compare the clinical utility of two dosage tapering regimens in Buprenorphine/Naloxone stabilized subjects for opiate detoxification.

Sex

All

Ages

15 to 99 years old

Volunteers

No Healthy Volunteers

Inclusion and exclusion criteria

Inclusion Criteria:

  • Females are not pregnant or lactating
  • Subjects meet DSM-IV criteria for opiate dependence, are medically and psychiatrically stable, and do not have a current history of benzodiazepine dependence abuse, dependence, or treatment

Trial contacts and locations

11

Loading...

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2024 Veeva Systems